HCK and ischemia: In addition, we developed a boron-containing selective HCK inhibitor, which inhibits M1-like polarization, restores autophagy activity in BMDM and kidney-derived macrophages and attenuates renal inflammation and fibrosis in mice with UUO and unilateral ischemia and reperfusion.